CRL SCHEDULE 13G/A: SEC filing
An institutional investor
Filed with the SEC on · accession 0000315066-26-002705
CRL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -4.1% by the first close after the filing.
Summary of the filing
An institutional investor filed an amended Schedule 13G regarding its beneficial ownership position in Charles River Laboratories International, Inc. The filing indicates a change in the holder's ownership stake.
Key details
How CRL stock reacted
Close before
$326.29
Nov 4, 2026
First close after
-4.07%
$313.02
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CRL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRL?
Click hereFrequently asked questions
What did CRL file with the SEC on Nov 5, 2026?
CRL filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G regarding its beneficial ownership position in Charles River Laboratories International, Inc. The filing indicates a change in the holder's ownership stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CRL stock react to this filing?
CRL closed at $326.29 before the filing and $313.02 on Nov 5, 2026 (-4.07%).
Other CRL SEC filings
Get alerts when CRL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days